Traws Pharma, Inc. (TRAW) Q4 2023 Annual Earnings
TRAW·Reported May 15, 2024·Before market open
Traws Pharma, Inc. reported Q4 2023 revenue of $113.0K, beat analyst consensus of $60.0K by $53.0K. Diluted EPS came in at $-6.00.
Revenue
$113.0Kbeat by $53.0K
Consensus: $60.0KDiluted EPS
$-6.00met estimate
Consensus: $-6.00
Financial Snapshot
Trailing eight quarters through Q4 2023
Q4 2023 Earnings FAQ
Common questions about Traws Pharma, Inc.'s Q4 2023 earnings report.
Traws Pharma, Inc. (TRAW) reported Q4 2023 earnings on May 15, 2024 before market open.
Traws Pharma, Inc. reported revenue of $113.0K and diluted EPS of $-6.00 for Q4 2023.
Revenue beat the consensus estimate of $60.0K by $53.0K. EPS beat the consensus estimate of $-6.00 by $0.00.
You can read the 10-K periodic report (0001558370-24-004525) directly on SEC EDGAR. The filing index links above go to sec.gov.